10-Q: USANA Health Sciences Q1 2026 Earnings Decline Amidst Segment Shifts

USANA Health Sciences reported a 0.3% increase in net sales to $250.2 million for Q1 2026, but net earnings attributable to USANA decreased by 20.1% to $7.5 million, impacted by lower operating margins and a higher tax rate.

Summary

• USANA Health Sciences reported net sales of $250.2 million for the first quarter of 2026, a slight increase of 0.3% ($0.7 million) compared to the prior year quarter.
• Net earnings attributable to USANA decreased by 20.1% to $7.5 million, down from $9.4 million in the prior year quarter.
• This earnings decline was primarily due to a lower operating margin and a higher effective tax rate.
• The Core Nutritional segment experienced a 3.0% decrease in net sales to $204.4 million, driven by a 12.0% drop in active customers, though average spend per customer increased by 5.6%.
• The Hiya segment saw a 13.3% decrease in net sales to $32.2 million, attributed to a lower customer base and reduced customer acquisitions.
• The Rise segment showed significant growth with a 740.7% increase in net sales to $13.7 million, largely due to the launch of 'Protein Pop' in major retailers.
• Consolidated gross profit margin decreased by 280 basis points to 76.2%, impacted by the lower-margin Rise segment and production inefficiencies in the Core Nutritional segment.
• Selling, general, and administrative expenses decreased by $3.2 million in absolute terms, benefiting from cost realignment strategies in the Core Nutritional segment and leverage from higher sales in the Rise segment.
• The effective tax rate increased to 55.0% from 44.5% in the prior year, due to lower consolidated earnings projections and an unfavorable change in the mix of taxable income by market.
• Diluted earnings per share decreased to $0.41 from $0.49 in the prior year quarter.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to the significant decrease in net earnings, decline in active customers in the core business, and increased tax rate, despite some positive growth in a smaller segment.

Positives

• Net sales saw a modest increase of 0.3% to $250.2 million.
• The Rise segment experienced substantial growth with net sales increasing by 740.7% to $13.7 million.
• Average spend per active customer in the Core Nutritional segment increased by 5.6%.
• Selling, general, and administrative expenses decreased by $3.2 million in absolute terms.
• The company maintains a strong cash position with $162.8 million in cash and cash equivalents as of April 4, 2026.
• The company believes its current liquidity, cash flow from operations, and line of credit are sufficient to meet its needs.

Negatives

• Net earnings attributable to USANA decreased by 20.1% to $7.5 million.
• The Core Nutritional segment's net sales decreased by 3.0% to $204.4 million.
• Active customers in the Core Nutritional segment decreased by 12.0%.
• The Hiya segment's net sales decreased by 13.3% to $32.2 million.
• Consolidated gross profit margin decreased by 280 basis points to 76.2%.
• The effective tax rate increased significantly to 55.0% from 44.5%.
• Diluted earnings per share decreased to $0.41 from $0.49.

Risks

• Dependence on the Core Nutritional direct sales business model and the activities of independent Brand Partners.
• Evolution to an omni-channel health and wellness company and dependence on acquired direct-to-consumer businesses (Hiya and Rise).
• Ability to invest in R&D, innovate, and release new products.
• Extensive regulation of the Core Nutritional business and uncertainties in interpretation and enforcement of laws in various markets.
• Risks associated with operating in China, including direct selling, data privacy, and economic changes.
• Export control and trade sanctions laws that could impair international competitiveness.
• Brand Partner Compensation Plan potentially being viewed negatively or failing to achieve objectives.
• Product liability claims and other liabilities associated with products.
• Challenges in expanding into new international markets, including delays and regulatory compliance.
• Macroeconomic conditions, including inflation, slower economic growth, and supply chain disruptions.
• Hiya's growth strategy, including expansion and adaptation to digital marketing changes.
• Rise's dependence on key retailers and the risk of future orders not materializing.
• Political events, natural disasters, pandemics, or health crises impacting economic conditions and consumer behavior.
• Changes in the legal and regulatory environment, including environmental, health, safety, data security, trade policies, and taxation.
• Geopolitical tensions and conflicts affecting operations.
• Volatile fluctuations in foreign currency exchange rates.
• Noncompliance with data privacy laws or security breaches.
• Shortages of raw materials, disruptions to contract manufacturers, and supply chain issues.
• Compliance with debt covenants in the credit facility.
• Litigation, tax, and legal compliance risks.
• Information technology system failures, data security breaches, and cybersecurity attacks.
• Acquisition and divestiture risks.
• Human capital risks, including attracting and retaining Brand Partner leaders and key management personnel.
• Ability to protect and enforce intellectual property.
• Ability to effectively and compliantly incorporate and utilize artificial intelligence technology.

Future Outlook

The company believes its current liquidity, cash flow from operations, and line of credit are sufficient to cover operating and capital needs. However, it acknowledges that additional financing may be required if an adverse operating environment or unanticipated capital expenditure requirements arise, or for expansion, acquisitions, or other strategic initiatives. Such financing could involve debt or equity, potentially leading to dilution.

Management Comments

• The modest increase in sales is the result of incremental net sales of $12.0 million for Rise, partially offset by a decline in both the Core Nutritional and Hiya segments of $6.4 million and $4.9 million, respectively.
• Net earnings attributable to USANA for the first quarter of 2026 were $7.5 million, a decrease of 20.1% compared with $9.4 million during the prior-year quarter. The change is primarily attributable to a lower operating margin and a higher effective tax rate in the current-year quarter.
• The decrease in Core Nutritional net sales was mainly due to a 12.0% decrease in active Customers, partially offset by a 5.6% increase in average spend per active Customer.
• Net sales in the Hiya segment for the three-month period ended April 4, 2026 were $32.2 million, down 13.3% when compared to the corresponding period of 2025. The decrease was primarily the result of a lower customer base and a decrease in customer acquisitions.
• Net sales in the Rise segment for the three-month period ended April 4, 2026 were $13.7 million, up 740.7% when compared to the corresponding period of 2025. The increase was primarily the result of the launch of Protein Pop in large national retailers and club retailers.
• Consolidated gross profit decreased 280 basis points to 76.2% of net sales, down from 79.0% in the prior-year quarter. The decrease in gross profit is largely attributed to an approximate 370 basis point unfavorable impact on consolidated results from incremental net sales for Rise, which carry lower gross margins relative to the Core Nutritional segment.
• The year-to-date effective tax rate increased to 55.0% from the 44.5% reported in the comparable period of fiscal 2025. The higher effective tax rate is due to lower consolidated earnings projections and an unfavorable change in mix of taxable income by market.
• Diluted earnings per share attributable to USANA decreased to $0.41 as compared to $0.49 reported in the prior-year quarter primarily as a result of the substantially higher income tax provision as well as lower earnings from operations in the current-year quarter.
• We believe our current cash balances, future cash provided by operations, and amounts available under our line of credit will be sufficient to cover our operating and capital needs in the ordinary course of business for the foreseeable future.

Industry Context

StockSavvy.ai notes that USANA's Q1 2026 results reflect a dynamic shift within the health and wellness sector, characterized by the integration of direct-to-consumer (DTC) and retail channels alongside traditional direct selling. The decline in the Core Nutritional segment's active customers, while offset by increased average spend, highlights a common challenge in mature direct selling models. The significant growth in the Rise segment, driven by retail expansion, and the continued strategic importance of the Hiya acquisition, demonstrate the company's efforts to diversify revenue streams and adapt to evolving consumer purchasing habits, mirroring broader industry trends towards omni-channel strategies.

Comparison to Industry Standards

• The decline in active customers for the Core Nutritional segment (12.0% year-over-year) is a concern, as many direct selling companies aim for consistent customer base growth. For instance, companies like Amway and Herbalife have historically focused on expanding their global network of distributors and customers, though they also face challenges in mature markets.
• The significant revenue growth in the Rise segment (740.7%) is exceptional and suggests successful penetration into the retail channel, which is a key growth area for many consumer packaged goods companies. This contrasts with the slower growth or decline seen in some traditional CPG categories.
• The increase in average spend per active customer in the Core Nutritional segment (5.6%) is a positive indicator, suggesting that loyal customers are increasing their purchases, a trend that can help offset volume declines.
• The higher effective tax rate (55.0%) is notably higher than the statutory U.S. corporate tax rate, indicating potential impacts from international operations, tax jurisdiction mix, or specific tax provisions. Industry benchmarks for effective tax rates vary widely by company and geography, but this rate appears elevated.
• The gross profit margin of 76.2% for the consolidated entity is strong, particularly for a company involved in nutritional products. However, the decline from 79.0% is attributed to the lower-margin Rise segment, a common trade-off when expanding into retail channels which often have lower margins than direct-to-consumer or direct selling models.

Legal Proceedings

• The company is involved in various lawsuits, claims, and other legal matters arising in the ordinary course of business, including those related to products, intellectual property, supplier relationships, distributors, competitors, and employees. Management does not currently believe these matters, individually or in aggregate, will have a material adverse effect on the company's financial condition, liquidity, or results of operations.

Stakeholder Impact

• Shareholders: Potential dilution from future financing, decreased earnings per share, and overall negative sentiment impacting stock price.
• Brand Partners: Continued reliance on the compensation plan, potential impact of declining active customers in Core Nutritional segment, and opportunities in the growing Rise segment.
• Customers: Continued access to nutritional, personal care, and wellness products through various channels; potential impact of pricing and product availability.
• Suppliers: Continued demand for raw materials and finished goods, with potential for supply chain disruptions noted as a risk.
• Creditors: Company's ability to meet debt covenants is highlighted, with a strong liquidity position noted.

Next Steps

• Continue to monitor the performance of the Core Nutritional, Hiya, and Rise segments.
• Evaluate the impact of cost realignment strategies implemented in Q4 2025.
• Assess the effectiveness of Hiya's expansion into retail and UK/Canada markets.
• Monitor the performance of Rise's new product 'Protein Pop' and its contribution to sales.
• Manage foreign currency exchange rate fluctuations.
• Continue to comply with debt covenants under the Credit Agreement.
• Evaluate and potentially adopt new accounting standards (ASU 2024-03 and ASU 2025-06).

Key Dates

Recommendation

While the decline in net earnings and core customer base is concerning, the significant growth in the Rise segment and the company's strong liquidity position suggest potential for recovery. The company is navigating a challenging market and integrating new business models. A 'hold' recommendation reflects a wait-and-see approach pending further evidence of stabilization and growth across all segments.

Keywords

USANA Health Sciences, 10-Q Filing, Quarterly Report, Nutritional Supplements, Health and Wellness, Direct Selling, Direct-to-Consumer, Omni-channel, Core Nutritional, Hiya, Rise Bar, Financial Results, Net Sales, Net Earnings, Earnings Per Share, Brand Partners, Active Customers, Asia Pacific, China, Americas, Europe, Gross Profit, Operating Expenses, Selling General Administrative, Income Taxes, Liquidity, Capital Resources, Market Risk, Internal Controls